Johnson & Johnson Escapes Lawsuit Over Ex-CEO’s Pay

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A federal judge dismisses a lawsuit accusing Johnson & Johnson of over-paying former CEO William Weldon.

Johnson & Johnson (NYSE:JNJ) yesterday escaped a shareholders derivative lawsuit alleging that the company over-paid former CEO William Weldon, who presided over a spate of recalls that bedeviled the healthcare giant a few years back.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC